About Procare Pharma Private Limited
Data last updated:
Procare Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85191DL2013PTC262846. Its GSTIN is 05AAHCP5296K1ZX (Uttarakhand). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rana Rajesh Kumar and Sanjiw Kumar Singh.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 786 Third Floor Cr Park, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.42 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹55.45 Lakh (net margin 5.9%) and EBITDA of ₹98.6 Lakh (EBITDA margin 10.5%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 35% over five years.
As per MCA filings, the company has open charges of ₹14.07 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website procarepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressE – 786 Third Floor Cr Park, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Procare Pharma Private Limited
The main business activity of Procare Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Procare Pharma Private Limited FY 2025 filings available
Procare Pharma Private Limited reported revenue of ₹9.42 Cr (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Procare Pharma Private Limited
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 35%. EBITDA rose 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Procare Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹98.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹55.45 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Procare Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Procare Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Procare Pharma Private Limited
Procare Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rana Rajesh Kumar Also directs: Protech Cold Storage Private Limited, SKRR Pharma Solutions Private Limited, Alice Medicare Private Limited and 2 more | Director | 31 Jul 2014 | 12 Years 2 Months | Current |
| Sanjiw Kumar Singh Also directs: New Pharma Private Limited, Affordmed Foundation, Protech Cold Storage Private Limited and 2 more | Director | 27 Dec 2013 | 12 Years 9 Months | Current |
| Renu Singh Also directs: Affordmed Foundation, SKRR Pharma Solutions Private Limited, Alice Medicare Private Limited and 1 more | Director | 12 Oct 2016 | 10 Years 0 Months | Current |
Peer Comparison of Procare Pharma Private Limited
Procare Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glory Pharmachem India Private Limited | ₹9.45 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | Hyderabad, Telangana, India |
| Guru Mahima Agros Private Limited | ₹9.43 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Bholath, Punjab, India |
| Avacare India Private Limited | ₹9.43 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Mumbai, Maharashtra, India |
| RPS Biotech Private Limited | ₹9.43 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Satara, Maharashtra, India |
| Medisphere Life Sciences Private Limited | ₹9.43 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Procare Pharma Private Limited this company | ₹9.42 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | New Delhi, Delhi, India |
| Delbruk Lifescience Private Limited | ₹9.41 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Kolkata, West Bengal, India |
| Sumangalam Formulations Private Limited | ₹9.39 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Vilayat, Gujarat, India |
| Zevemed Healthcare Private Limited | ₹9.39 Cr (FY 2024) | •••• | •••• | 117.0% | •••• | Secunderabad, Telangana, India |
| Organon Homoeo Laboratory Pvt Ltd | ₹9.39 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Kolkata, West Bengal, India |
| Emmchak Formulations Private Limited | ₹9.37 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Tiruchirappalli, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Procare Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Procare Pharma Private Limited
Procare Pharma Private Limited is audited by NIKHIL RELAN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIKHIL RELAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Procare Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Procare Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2025 | Others | ₹8 Cr | Open |
| 22 Apr 2024 | Axis Bank Limited | ₹6.07 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Procare Pharma Private Limited
Employment history and EPFO contributions of people linked to Procare Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Procare Pharma Private Limited
Procare Pharma Private Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Pramod Kumar Sharma ceased to be Director on 01 Mar 2021.
Credit Ratings, Litigation & Regulatory Alerts for Procare Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Procare Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Procare Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Procare Pharma Private Limited
Procare Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAHCP5296K1ZX | Uttarakhand | Active | 01 Jul 2017 |
| 06AAHCP5296K1ZV | Haryana | Active | 27 Mar 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Procare Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Procare Pharma Private Limited
Procare Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 December 2013 (13+ years old) and is registered under CIN U85191DL2013PTC262846.
Procare Pharma reported revenue of ₹9.42 Cr for FY 2025 (down 21% YoY).
Procare Pharma has 3 current directors:
- Rana Rajesh Kumar - Director
- Sanjiw Kumar Singh - Director
- Renu Singh - Director
Procare Pharma reported a net profit of ₹55.45 Lakh (net margin 5.9%) and EBITDA of ₹98.6 Lakh (EBITDA margin 10.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Procare Pharma is 17% over three years and 35% over five years. In the latest year (FY 2025) revenue fell 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Procare Pharma is 05AAHCP5296K1ZX, registered in Uttarakhand. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAHCP5296K1ZV (Haryana).
The CIN (Corporate Identification Number) of Procare Pharma is U85191DL2013PTC262846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Procare Pharma was incorporated on 27 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Procare Pharma by revenue are Glory Pharmachem India Private Limited, Guru Mahima Agros Private Limited, Avacare India Private Limited, RPS Biotech Private Limited, Medisphere Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Pramod Kumar Sharma ceased to be Director on 01 Mar 2021. Renu Singh ceased to be Additional Director on 30 Sep 2017. Renu Singh was appointed as Director on 12 Oct 2016. Procare Pharma has 6 board changes on record in total.
Procare Pharma can be reached through the website procarepharma.com. Its registered office is in New Delhi, Delhi, India.